Pacer Advisors
PRAX icon

Pacer Advisors’s Praxis Precision Medicines PRAX Stock Holding History

Pacer Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64K Buy
+192
New +$60.8K ﹤0.01% 1981
2024
Q3 		– Sell
-235
Closed -$9.72K – 2660
2024
Q2 		$9.72K Buy
+235
New +$11.1K ﹤0.01% 3555
2021
Q2 		– Sell
-58
Closed -$29K – 1514
2021
Q1 		$29K Buy
+58
New +$41.2K ﹤0.01% 1484

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Pacer Advisors's PRAX Position: Q2 2026 in Review

Pacer Advisors opened a new position in Praxis Precision Medicines (PRAX) in Q2 2026: 192 shares worth $64K. The stake represents ﹤0.01% of the portfolio and ranks #1981 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in PRAX as recently as Q2 2024.

Pacer Advisors first reported a position in PRAX in Q1 2021 and has held it in 3 quarters since. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Pacer Advisors held 192 shares of Praxis Precision Medicines worth $64K as of Q2 2026.
  • Praxis Precision Medicines was a new Pacer Advisors position in Q2 2026.
  • Praxis Precision Medicines made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #1981 holding.
  • Pacer Advisors first reported a position in Praxis Precision Medicines in Q1 2021 and has held it in 3 quarters since.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.